| 000 | 01746 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516225630.0 | ||
| 264 | 0 | _c20150219 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1474-4457 | ||
| 024 | 7 |
_a10.1016/S1473-3099(14)70841-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTabrizi, Sepehr N | |
| 245 | 0 | 0 |
_aAssessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. _h[electronic resource] |
| 260 |
_bThe Lancet. Infectious diseases _cOct 2014 |
||
| 300 |
_a958-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAlphapapillomavirus _ximmunology |
| 650 | 0 | 4 |
_aAustralia _xepidemiology |
| 650 | 0 | 4 | _aCross Protection |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHealth Plan Implementation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Herd _ximmunology |
| 650 | 0 | 4 |
_aPapillomavirus Infections _xepidemiology |
| 650 | 0 | 4 |
_aPapillomavirus Vaccines _ximmunology |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBrotherton, Julia M L | |
| 700 | 1 | _aKaldor, John M | |
| 700 | 1 | _aSkinner, S Rachel | |
| 700 | 1 | _aLiu, Bette | |
| 700 | 1 | _aBateson, Deborah | |
| 700 | 1 | _aMcNamee, Kathleen | |
| 700 | 1 | _aGarefalakis, Maria | |
| 700 | 1 | _aPhillips, Samuel | |
| 700 | 1 | _aCummins, Eleanor | |
| 700 | 1 | _aMalloy, Michael | |
| 700 | 1 | _aGarland, Suzanne M | |
| 773 | 0 |
_tThe Lancet. Infectious diseases _gvol. 14 _gno. 10 _gp. 958-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1473-3099(14)70841-2 _zAvailable from publisher's website |
| 999 |
_c24083497 _d24083497 |
||